粤公网安备 44011302004783号 continued
投放时间: 2025-06-25 08:00:00
Treatment for HER2-Positive Early Breast Cancer With Residual Invasive Disease After Neoadjuvant Therapy
搜索关键词 HER2 positive, breast cancer, neoadjuvant therapy, residual disease, targeted therapy, cancer treatment, invasive disease, oncology treatment, breast cancer survival, cancer research优势 Targets HER2-positive breast cancer,Addresses residual invasive disease,Follows neoadjuvant therapy
展示估值
13077
热度
1986
最新发现时间
2025-06-25 08:00:00
投放天数
210
素材信息
素材类型
素材尺寸
主页ID8289873642116217666
主页名字Cancer Therapy Advisor
产品信息
适用范围
人民币汇率走势
CNY
关注我们
新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有，未经许可，禁止以任何形式转载。